The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease
NCT04206176 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2020-05-21
Summary
This study aims to assess the effects of low dose ticagrelor on platelet function testing in patients with stable coronary artery disease.
Conditions
- Platelet Dysfunction Due to Drugs
Interventions
- DRUG
-
Ticagrelor
Ticagrelor 45mg twice daily per oral administration
Sponsors & Collaborators
-
The University of The West Indies
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2020-03-31
- Completion
- 2020-03-31
- FDA Drug
- Yes
Countries
- Trinidad and Tobago
Study Locations
More Related Trials
-
Study of LC23-1306 in Healthy Male Subjects
NCT01526577 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage
NCT02214654 ·Status: UNKNOWN
-
Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor
NCT01734772 ·Status: COMPLETED ·Phase: PHASE1
-
A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients
NCT04307511 ·Status: RECRUITING ·Phase: PHASE4
-
Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
NCT02230527 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
NCT01587651 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
NCT02284048 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects
NCT04088123 ·Status: WITHDRAWN
-
A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
NCT03027934 ·Status: WITHDRAWN ·Phase: PHASE4
-
EndoTic - Endothelium and Ticagrelor
NCT02244710 ·Status: COMPLETED ·Phase: NA
-
Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study
NCT02091921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting
NCT02487732 ·Status: COMPLETED ·Phase: PHASE4
-
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
NCT02298088 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake
NCT01690884 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.
NCT04069234 ·Status: WITHDRAWN ·Phase: PHASE3
-
In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease
NCT05716646 ·Status: NOT_YET_RECRUITING
-
PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment
NCT04634162 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
NCT02257294 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery
NCT02352402 ·Status: UNKNOWN ·Phase: PHASE3
-
Ticagrelor and Endothelial Function
NCT02261922 ·Status: UNKNOWN ·Phase: PHASE4
-
The ACS Ethnicity Platelet Function Study
NCT01829659 ·Status: COMPLETED
-
Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
NCT01852214 ·Status: COMPLETED ·Phase: NA
-
Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old
NCT04122170 ·Status: COMPLETED ·Phase: PHASE2
-
TART - Troglitazone Atherosclerosis Regression Trial
NCT00116545 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
NCT03950843 ·Status: UNKNOWN ·Phase: PHASE3